Literature for peptidase S01.231: urokinase-type plasminogen activator

(References are filtered for relevance to Knockout. To remove the filter click here. See explanation.)

2017
1. Zhao,K., Liu,Y., Xiong,Z., Hu,L. and Xiong,C.L.
   Tissue-specific inhibition of urokinase-type plasminogen activator expression in the testes of mice by inducible lentiviral RNA interference causes male infertility
   Reprod Fertil Dev29, 2149-2156. PubMed  Europe PubMed DOI  K
2014
2. Popa,N.L., Wergedal,J.E., Lau,K.H., Mohan,S. and Rundle,C.H.
   Urokinase plasminogen activator gene deficiency inhibits fracture cartilage remodeling
   J Bone Miner Metab32, 124-135. PubMed  Europe PubMed DOI  K
2013
3. Rao Malla,R., Gopinath,S., Alapati,K., Gorantla,B., Gondi,C.S. and Rao,J.S.
   Knockdown of cathepsin B and uPAR inhibits CD151 and alpha3beta1 integrin-mediated cell adhesion and invasion in glioma
   Mol Carcinog52, 777-790. PubMed  Europe PubMed DOI  K
2012
4. Kawao,N., Nagai,N., Tamura,Y., Horiuchi,Y., Okumoto,K., Okada,K., Suzuki,Y., Umemura,K., Yano,M., Ueshima,S., Kaji,H. and Matsuo,O.
   Urokinase-type plasminogen activator and plasminogen mediate activation of macrophage phagocytosis during liver repair in vivo
   Thromb Haemost107, 749-759. PubMed  Europe PubMed DOI  K
2010
5. Jogi,A., Rono,B., Lund,I.K., Nielsen,B.S., Ploug,M., Hoyer-Hansen,G., Romer,J. and Lund,L.R.
   Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice
   PLoS ONE5, e12746-e12746. PubMed  Europe PubMed DOI  K
2005
6. [YEAR:7-10-2005]Almholt,K., Lund,L.R., Rygaard,J., Nielsen,B.S., Dano,K., Romer,J. and Johnsen,M.
   Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice
   Int J Cancer113, 525-532. PubMed  Europe PubMed DOI  K
2003
7. Daci,E., Everts,V., Torrekens,S., Van Herck,E., Tigchelaar-Gutterr,W., Bouillon,R. and Carmeliet,G.
   Increased bone formation in mice lacking plasminogen activators
   J Bone Miner Res18, 1167-1176. PubMed  Europe PubMed DOI  K
2001
8. [YEAR:15-7-2001]Kahr,W.H.A., Zheng,S.L., Sheth,P.M., Pai,M., Cowie,A., Bouchard,M., Podor,T.J., Rivard,G.E. and Hayward,C.P.M.
   Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator
   Blood98, 257-265. PubMed  Europe PubMed DOI  K
1997
9. Shapiro,R.L., Duquette,J.G., Nunes,I., Roses,D.F., Harris,M.N., Wilson,E.L. and Rifkin,D.B.
   Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles
   Am J Pathol150, 359-369. PubMed  Europe PubMed  K
1995
10. Wilhelm,O., Schmitt,M., Hohl,S., Senekowitsch,R. and Graeff,H.
    Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice
    Clin Exp Metastasis13, 296-302. PubMed  Europe PubMed DOI  K
1994
11. Carmeliet,P., Schoonjans,L., Kieckens,L., Ream,B., Degen,J., Bronson,R., De Vos,R., van den Oord,J.J., Collen,D. and Mulligan,R.C.
    Physiological consequences of loss of plasminogen activator gene function in mice
    Nature368, 419-424. PubMed  Europe PubMed DOI  K